Astria Therapeutics

+$0.22 (+7.01%) Today
-$0.03 (-0.89%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATXS and other ETFs, options, and stocks.

About ATXS

Astria Therapeutics, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is STAR-0215, which is intended to treat Hereditary Angioedema, a rare genetic disorder characterized by severe, recurrent, unpredictable, painful, and sometimes life-threatening swelling in the face, limbs, abdomen, and airway.

CEO
Jill C. Milne
Employees
29
Headquarters
Boston, Massachusetts
Founded
2008

ATXS Key Statistics

Market cap
43.74M
Price-Earnings ratio
—
Dividend yield
—
Average volume
13.87K
High today
$3.37
Low today
$3.16
Open price
$3.16
Volume
21.88K
52 Week high
$15.72
52 Week low
$3.02

ATXS Earnings

-$1.18
-$0.79
-$0.39
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure